| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2022 | Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants | Chen C.-P.; Kuan-Ying A. Huang ; Shih S.-R.; Lin Y.-C.; Cheng C.-Y.; Huang Y.-C.; Lin T.-Y.; Cheng S.-H. | Microbiology Spectrum | 1 | 1 | |
| 2002 | Antibiotic usage in community-acquired infections in hospitals in Taiwan | Ho M.; Chang F.-Y.; Yin H.-C.; Ben R.-J.; LUAN-YIN CHANG ; Chen P.-Y.; Cheng S.-H.; Chen S.-T.; Huang F.-L.; Lin H.-C.; Lu D.C.T.; Wang N.-C.; JANN-TAY WANG | Journal of the Formosan Medical Association | 8 | 8 | |
| 2021 | Breadth and function of antibody response to acute SARS-CoV-2 infection in humans | Kuan-Ying A. Huang ; Tan T.K.; Chen T.-H.; Huang C.-G.; Harvey R.; Hussain S.; Chen C.-P.; Harding A.; Gilbert-Jaramillo J.; Liu X.; Knight M.; Schimanski L.; Shih S.-R.; Lin Y.-C.; Cheng C.-Y.; Cheng S.-H.; Huang Y.-C.; Lin T.-Y.; Jan J.-T.; Ma C.; James W.; Daniels R.S.; McCauley J.W.; Rijal P.; Townsend A.R. | PLoS Pathogens | 37 | 33 | |
| 2020 | A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response | Lin Y.-C.; Cheng C.-Y.; Chen C.-P.; Cheng S.-H.; SUI-YUAN CHANG ; PO-REN HSUEH | International Journal of Infectious Diseases | 14 | 12 | |
| 2018 | Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan | Li C.-W.; Yang C.-J.; HSIN-YUN SUN ; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; YU-SHAN HUANG ; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Cheng S.-H.; Ko W.-C.; CHIEN-CHING HUNG | PLoS ONE | 16 | 15 | |
| 2019 | Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study | Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN ; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; CHIEN-CHING HUNG ; Wang N.-C.; for the Taiwan HIV Study Group | Journal of Microbiology, Immunology and Infection | 7 | 6 | |
| 2001 | Correlates of antibiotic use in Taiwan hospitals | McDonald L.C.; Yu H.T.; Yin H.C.; Hsiung C.A.; CHIEN-CHING HUNG ; Ho M.; Gung C.; Gung S.-T.; Hsu M.-C.; Ben R.-J.; Lu D.C.T.; Lin H.-C.; Cheng S.-H.; Chen Y.-H.; Chen P.-Y.; Huang F.-L.; Chang F.-Y.; Wang N.-C.; Antibiotic Use Working Group | Infection Control and Hospital Epidemiology | 14 | 13 | |
| 2019 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials | Cahn P.; Madero J.S.; Arribas J.R.; Antinori A.; Ortiz R.; Clarke A.E.; CHIEN-CHING HUNG ; Rockstroh J.K.; Girard P.-M.; Sievers J.; Man C.; Currie A.; Underwood M.; Tenorio A.R.; Pappa K.; Wynne B.; Fettiplace A.; Gartland M.; Aboud M.; Smith K.; Cassetti L.; David D.; Figueras L.; Losso M.; Lopardo G.; Lupo S.; Porteiro N.; Sánchez M.; Bloch M.; Cooper D.; Finlayson R.; Kelleher A.; Koh K.; Lewis D.; McMahon J.; Moore R.; Roth N.; Shields M.; De Wit S.; Florence E.; Goffard J.-C.; Demeester R.; Lacor P.; Vandercam B.; Vandekerckhove L.; Angel J.; Baril J.-G.; Conway B.; De Pokomandy A.; Szabo J.; Walmsley S.; Bouchaud O.; Chidiac C.; Delobel P.; Goujard C.; Katlama C.; Molina J.-M.; Pialoux G.; Philibert P.; Bogner J.; Esser S.; Krznaric I.; Lehmann C.; Spinner C.; Stellbrink H.-J.; Stephan C.; Stoehr A.; Barchi E.; Caramello P.; Castelli F.; Cattelan A.M.; D'Arminio Monforte A.; Di Biagio A.; Di Perri G.; Gori A.; Maggiolo F.; Menzaghi B.; Migliorino G.; Mussini C.; Penco G.; Puoti M.; Rizzardini G.; Gulminetti R.; Lazzarin A.; Quirino T.; Sighinolfi L.; Viale P.; Amaya Tapia G.; Andrade Villanueva J.; Granados Reyes E.R.; Perez Rios A.; Santoscoy Gomez M.; Den Hollander J.; Rijnders B.; Hidalgo J.A.; Hercilla Vasquez L.; Illescas L.; Olczak A.; Mansinho K.; Correia Pacheco P.P.; Teófilo E.; Saraiva da Cunha J.; Sarmento e Castro R.; Serrão R.; Arbune M.; Jianu C.; Oprea A.; Preotescu L.; Prisacariu L.-J.; Belonosova E.; Borodkina O.; Chernova O.; Gankina N.; Kizhlo S.; Kulagin V.; Kurina N.; Nagimova F.; Pokrovsky V.; Ryamova E.; Voronin E.; Yakovlev A.; Kaplan R.; Lee S.H.; Kim S.-W.; Kim S.-I.; Kim W.J.; Antela Lopez A.; Casado Osorio J.L.; Castaño Carracedo M.A.; De Los Santos Gil I.; Estrada Perez V.; Falco Ferrer V.; Force L.; Galinda Puerto M.J.; Garcia Deltoro M.; Gatell J.M.; Goenaga Sanchez M.A.; González Cordón A.; Knobel H.; Lopez Bernaldo de Quiros J.C.; Losa Garcia J.E.; Masia M.; Montero-Alsonso M.; Ocampo Hermida A.; Pasquau Liaño J.; Portilla Sogorb J.; Pulido Ortega F.; Rivera Roman A.; Santos Fernandez J.R.; Torres Perea R.; Troya Garcia J.; Viciana Fernandez P.; Calmy A.; Hauser C.; Fehr J.; Cheng S.-H.; Ko W.-C.; Lin H.-H.; Lu P.-L.; Tseng Y.-T.; Wang N.-C.; Wong W.-W.; Yang C.-J.; Arduino R.; Benson P.; Berhe M.; Bredeek F.; Brinson C.; Campbell T.; Crofoot G.; Cunningham D.; DeJesus E.; Dretler R.; Eron J.; Fife K.; Fichtenbaum C.; Flamm J.; Goldstein D.; Gupta S.; Hagins D.; Hoffman-Terry M.; Jayaweera D.; Kinder C.; Klein D.; McDonald C.; Mills A.; Nahass R.; Osiyemi O.; Overton E.; Parks D.; Prelutsky D.; Ramgopal M.; Schrader S.; Sha B.; Simon G.; Sims J.; Skiest D.; Slim J.; Tashima K.; Thedinger B.; Gazzard B.; Fox J.; Johnson M.; Kegg S.; Khoo S.; Mazhude C.; Orkin C.; Schembri G.; Ustianowski A.; GEMINI Study Team | The Lancet | 210 | 205 | |
| 2021 | Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV | Lee Y.-L.; KUAN-YIN LIN ; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | International Journal of Antimicrobial Agents | 1 | 0 | |
| 2019 | Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression | Hung T.-C.; Chen G.-J.; Cheng S.-H.; Chen J.-H.; Wei J.-L.; Cheng C.-Y.; CHIEN-CHING HUNG | Journal of Microbiology, Immunology and Infection | 1 | 1 | |
| 2019 | Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors | Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN ; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; CHIEN-CHING HUNG ; on behalf of the Taiwan HIV Study Group | Hepatology | 14 | 13 | |
| 2021 | Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients | YU-SHAN HUANG ; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; HSIN-YUN SUN ; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | Journal of acquired immune deficiency syndromes (1999) | 6 | 6 | |
| 1988 | Efficacy of a Mass Hepatitis B Vaccination Program in Taiwan: Studies on 3464 Infants of Hepatitis B Surface Antigen—Carrier Mothers | Hsu H.-M. ; DING-SHINN CHEN ; Chuang C.-H.; Lu J.-C.; Jwo D.-M.; Lee C.-C.; Lu H.-C.; Cheng S.-H.; Wang Y.-F.; Wang C.-Y. | JAMA: The Journal of the American Medical Association | 158 | 0 | |
| 2012 | Enhancement of laser action in ZnO nanorods assisted by surface plasmon resonance of reduced graphene oxide nanoflakes | Cheng S.-H.; Yeh Y.-C.; Lu M.-L.; Chen C.-W.; CHUN-WEI CHEN ; YANG-FANG CHEN | Optics Express | 23 | 21 | |
| 2021 | Erratum: Breadth and function of antibody response to acute SARS-CoV-2 infection in humans (PLoS Pathog (2021) 17:2 (e1009352) DOI: 10.1371/journal.ppat.1009352) | Kuan-Ying A. Huang ; Tan T.K.; Chen T.-H.; Huang C.-G.; Harvey R.; Hussain S.; Chen C.-P.; Harding A.; Gilbert-Jaramillo J.; Liu X.; Knight M.; Schimanski L.; Shih S.-R.; Lin Y.-C.; Cheng C.-Y.; Cheng S.-H.; Huang Y.-C.; Lin T.-Y.; Jan J.-T.; Ma C.; James W.; Daniels R.S.; McCauley J.W.; Rijal P.; Townsend A.R. | PLoS Pathogens | 0 | 0 | |
| 2005 | Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan | Lauderdale T.-L.; Chang F.-Y.; Ben R.-J.; Yin H.-C.; Ni Y.-H.; Tsai J.-W.; Cheng S.-H.; JANN-TAY WANG ; Liu Y.-C.; Cheng Y.-W.; Chen S.-T.; Fung C.-P.; Chuang Y.-C.; Cheng H.-P.; Lu D.C.T.; Liu C.-J.; Huang I.-W.; Hung C.-L.; Hsiao C.-F.; Ho M. | Respiratory Medicine | 89 | 80 | |
| 2017 | Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan | Lee Y.-L.; KUAN-YIN LIN ; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG ; HSIN-YUN SUN ; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | PLoS ONE | 14 | 8 | |
| 2010 | Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: Impact of compromised immunity | HSIN-YUN SUN ; Lee H.-C.; Liu C.-E.; Yang C.-L.; Su S.-C.; Ko W.-C.; Lin C.-Y.; Tsai J.-J.; Wong W.-W.; Ho M.-W.; Cheng S.-H.; Lin Y.-H.; Miao W.-J.; CHIEN-CHING HUNG | Journal of Viral Hepatitis | 22 | 23 | |
| 2000 | The job opportunity is getting worse for public health graduates. Is that true? | Cheng S.-H.; PAU-CHUNG CHEN ; Lin C.-M. | Chinese Journal of Public Health | 0 | ||
| 2017 | Lectin-functionalized mesoporous silica nanoparticles for endoscopic detection of premalignant colonic lesions | Chen N.-T.; Souris J.S.; Cheng S.-H.; Chu C.-H.; Wang Y.-C.; Konda V.; Dougherty U.; Bissonnette M.; Mou C.-Y. ; Chen C.-T.; Lo L.-W. | Nanomedicine: Nanotechnology, Biology, and Medicine | 28 | 25 |  |
